Therapeutic potential of targeting mTOR in T-cell acute lymphoblastic leukemia (Review)

By                    

International Journal of Oncology, Vol. 45, Iss. 3, 2014-01 ,pp. : 909-918

Spandidos Publications

Access to resources Recommend Favorite

Targeting the mTOR pathway using deforolimus in cancer therapy

By Mahalingam Devalingam   Sankhala Kamalesh   Mita Alain   Giles Francis J   Mita Monica M  

Future Oncology, Vol. 5, Iss. 3, 2009-04 ,pp. : 291-303

Future Medicine

Access to resources Recommend Favorite

Targeting mTOR in cancer: renal cell is just a beginning

By Azim Hamdy  

Targeted Oncology, Vol. 5, Iss. 4, 2010-12 ,pp. : 269-280

Springer Publishing Company

Access to resources Recommend Favorite

Inhibition of mTOR Signaling by Quercetin in Cancer Treatment and Prevention

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 13, Iss. 7, 2013-09 ,pp. : 1025-1031

Bentham Science Publishers

Access to resources Recommend Favorite

Metformin sensitizes chemotherapy by targeting cancer stem cells and the mTOR pathway in esophageal cancer

By                

International Journal of Oncology, Vol. 45, Iss. 2, 2014-01 ,pp. : 567-574

Spandidos Publications

Access to resources Recommend Favorite